MCL1 and neoplasm: Myeloid cell leukemia-1 (MCL1) is one of anti-apoptotic Bcl-2 family proteins with a short half-life period, and previous work has demonstrated that up-regulation of MCL1 might inhibit apoptosis, chemoresistance, and cell cycle progression of tumor cells [4].